| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc2b03342511abc88f60c63f2acd96d0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-351 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335 |
| filingDate |
2017-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_926aa77cea010241f725a0a276a10a3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c812494aa1b8868e02bbdb572c87a21d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d589af7e4ee0b96ac2cd619ff42895a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7cf3ae7061cc6abcfa3ce4b262bf2d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6ab1ad1248d8c99745a80b87c1f3f65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c287e03f8ef13575ad25748e1502753e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_845ecbfd2a62b811216f05f4e926aa1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2aac7d25c10cfc45a13886f925f10162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_192fe69ce37d9756535b52bc46255991 |
| publicationDate |
2019-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2017339786-A1 |
| titleOfInvention |
Bryostatin compounds and methods of preparing the same |
| abstract |
Methods for preparing a variety of bryostatin compounds are provided. The subject methods provide for preparation of bryostatin 1 in multi-gram quantities in a low and unprecedented number of convergent synthetic steps from commercially available materials. The subject methods are scalable with low estimated material costs and can provide enough material to meet clinical needs. Also provided are a variety of bryostatin analog compounds, and prodrug forms thereof, which are synthetically accessible via the subject methods and pharmaceutical compositions including the same. |
| priorityDate |
2016-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |